Anima Biotech Announces Strategic Collaboration with Takeda to Discover and Develop mRNA Translation Modulators for Neurological Diseases on March 18, 2021 BERNARDSVILLE, N.J., March 18, 2021 (GLOBE NEWSWIRE) — Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company has entered into a [...] Read more »